SRI-35241
SRI-35241 is a thrombospondin TSP-1 inhibitor with a pIC50 of 8.12 nM against human targets. SRI-35241 inhibits the binding of TSP-1 to latent transforming growth factor-β-associated peptide (LAP) and blocks the activation of TGF-β. SRI-35241 shows a certain time-dependent property, with a plasma half-life of 1.8 h after intravenous administration. SRI-35241 can be used for the research of multiple myeloma and fibrotic diseases.
연구목적의 판매만을 진행합니다. 환자를 대상으로 한 판매는 하지 않습니다.
- CAS No.: 2307429-54-3
- 화학식: C11H22N4O3
- 분자량:258.32
-
보관:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
SRI-35241 inhibits thrombospondin 1-mediated TGF-β activation in human myeloma cells with a pIC50 of 8.12 nM[1].
SRI-35241 (10 nM; 10 min) inhibits binding of recombinant LAP to recombinant thrombospondin 1 type 1 repeats (P123) by ~85% at 10 nM in an indirect binding ELISA assay[1].
SRI-35241 has a half-life of 170 min in rat liver microsomes and >300 min in human liver microsomes, indicating improved microsomal stability compared to the parent compound[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Chemical Information
-
CAS No. 2307429-54-3
-
분자량 258.32
-
화학식 C11H22N4O3
-
SMILES
NC(C(C)(C)NC([C@@H](NC(C)=O)CCCN)=O)=O
-
선적
Room temperature in continental US; may vary elsewhere.
-
보관
Please store the product under the recommended conditions in the Certificate of Analysis.
순도&문서
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)